Report License
$4,123 $4,850
15% off
$4,840 $6,050
20% off
$5,845 $8,350
30% off
Order Review
Osteoporosis Drugs Market – By Type (Primary [Postmenopausal, Senile, Idiopathic], Secondary), Drug Class (Bisphosphonates, RANK Ligand, Parathyroid Hormone, HRT, SERMs), Route of Administration (Oral, Injectable), Distribution Channel & Forecast, 2024 – 2032
Report ID: GMI9420
Selected License: $8,350
Discount: $2,505
Order Total: $5,845
Need assistance?
Call us or write to us:
Phone : +1-302-846-7766
Toll-Free : +1-888-689-0688
Email: sales@gminsights.com
